Fetal hemoglobin Bart’s hydrops fetalis: pathophysiology, prenatal diagnosis and possibility of intrauterine treatment

References

• Chui DH. Alpha-thalassaemia and population health in Southeast Asia. Ann Hum Biol 2005;32:123–30.
   PubMed Web of Science ®Google Scholar
• Flint J, Hill AV, Bowden DK, et al. High frequencies of alpha-thalassaemia are the result of natural selection by malaria. Nature 1986;321:744–50.
   PubMed Web of Science ®Google Scholar
• Modell B, Darlison M. Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 2008;86:480–7.
   PubMed Web of Science ®Google Scholar
• Wanapirak C, Muninthorn W, Sanguansermsri T, et al. Prevalence of thalassemia in pregnant women at Maharaj Nakorn Chiang Mai Hospital. J Med Assoc Thai 2004;87:1415–18.
   PubMedGoogle Scholar
• Xu XM, Zhou YQ, Luo GX, et al. The prevalence and spectrum of alpha and beta thalassaemia in Guangdong Province: implications for the future health burden and population screening. J Clin Pathol 2004;57:517–22.
   PubMed Web of Science ®Google Scholar
• Yang Y, Li DZ. A survey of pregnancies with Hb Bart's disease in Mainland China. Hemoglobin 2009;33:132–6.
   PubMed Web of Science ®Google Scholar
• Xiong F, Sun M, Zhang X, et al. Molecular epidemiological survey of haemoglobinopathies in the Guangxi Zhuang Autonomous Region of Southern China. Clin Genet 2010;78:139–48.
   PubMed Web of Science ®Google Scholar
• Kwan WY, So CH, Chan WP, et al. Re-emergence of late presentations of fetal haemoglobin Bart's disease in Hong Kong. Hong Kong Med J 2011;17:434–40.
   PubMedGoogle Scholar
• Garcia-Diaz L, Carreto P, Costa-Pereira S, Antinolo G. Prenatal management and perinatal outcome in giant placental chorioangioma complicated with hydrops fetalis, fetal anemia and maternal mirror syndrome. BMC Pregnancy Childbirth 2012;12:72.
   PubMed Web of Science ®Google Scholar
• Traisrisilp K, Luewan S, Tongsong T. Pregnancy outcomes in women complicated by thalassemia syndrome at Maharaj Nakorn Chiang Mai Hospital. Arch Gynecol Obstet 2009;279:685–9.
   PubMed Web of Science ®Google Scholar
• Proust S, Philippe HJ, Paumier A, et al. Mirror pre-eclampsia: Ballantyne’s syndrome. Two cases. J Gynecol Obstet Biol Reprod (Paris) 2006;35:270–4.
   PubMedGoogle Scholar
• Wu LL, Wang CH, Li ZQ. Clinical study of 12 cases with obstetric mirror syndrome. Zhonghua Fu Chan Ke Za Zhi 2012;47:175–8.
   PubMedGoogle Scholar
• Braun T, Brauer M, Fuchs I, et al. Mirror syndrome: a systematic review of fetal associated conditions, maternal presentation and perinatal outcome. Fetal Diagn Ther 2010;27:191–203.
   PubMed Web of Science ®Google Scholar
• Sanguansermsri T, Thanaratanakorn P, Steger HF, et al. Prenatal diagnosis of hemoglobin Bart’s hydrops fetalis by HPLC analysis of hemoglobin in fetal blood samples. Southeast Asian J Trop Med Public Health 2001;32:180–5.
   PubMedGoogle Scholar
• Enzensberger C, Pulvermacher C, Degenhardt J, et al. Fetal loss rate and associated risk factors after amniocentesis, chorionic villus sampling and fetal blood sampling. Ultraschall Med 2012;33:E75–9.
   PubMedGoogle Scholar
• Enzensberger C, Pulvermacher C, Degenhardt J, et al. Outcome after second-trimester amniocentesis and first-trimester chorionic villus sampling for prenatal diagnosis in multiple gestations. Ultraschall Med 2014;35:166–72.
   PubMed Web of Science ®Google Scholar
• Liao C, Wei J, Li Q, et al. Efficacy and safety of cordocentesis for prenatal diagnosis. Int J Gynaecol Obstet 2006;93:13–17.
   PubMed Web of Science ®Google Scholar
• Tongsong T, Wanapirak C, Sirivatanapa P, et al. Prenatal eradication of Hb Bart's hydrops fetalis. J Reprod Med 2001;46:18–22.
   PubMed Web of Science ®Google Scholar
• Leung WC, Leung KY, Lau ET, et al. Alpha-thalassaemia. Semin Fetal Neonatal Med 2008;13:215–22.
   PubMed Web of Science ®Google Scholar
• Sirichotiyakul S, Luewan S, Srisupundit K, et al. Prenatal ultrasound evaluation of fetal Hb Bart's disease among pregnancies at risk at 11 to 14 weeks of gestation. Prenat Diagn 2014;34:230–4.
   PubMed Web of Science ®Google Scholar
• Thathan N, Traisrisilp K, Luewan S, et al. Screening for hemoglobin Bart's disease among fetuses at risk at mid-pregnancy using the fetal cardiac diameter to biparietal diameter ratio. BMC Pregnancy Childbirth 2014;14:230.
   PubMed Web of Science ®Google Scholar
• Lam YH, Ghosh A, Tang MH, et al. Early ultrasound prediction of pregnancies affected by homozygous alpha-thalassaemia-1. Prenat Diagn 1997;17:327–32.
   PubMed Web of Science ®Google Scholar
• Lam YH, Tang MH. Middle cerebral artery Doppler study in fetuses with homozygous alpha-thalassaemia-1 at 12-13 weeks of gestation. Prenat Diagn 2002;22:56–8.
   PubMed Web of Science ®Google Scholar
• Leung KY, Cheong KB, Lee CP, et al. Ultrasonographic prediction of homozygous alpha0-thalassemia using placental thickness, fetal cardiothoracic ratio and middle cerebral artery Doppler: alone or in combination? Ultrasound Obstet Gynecol 2010;35:149–54.
   PubMed Web of Science ®Google Scholar
• Tongsong T, Boonyanurak P. Placental thickness in the first half of pregnancy. J Clin Ultrasound 2004;32:231–4.
   PubMed Web of Science ®Google Scholar
• Tongsong T, Tatiyapornkul T. Cardiothoracic ratio in the first half of pregnancy. J Clin Ultrasound 2004;32:186–9.
   PubMed Web of Science ®Google Scholar
• Leung KY, Liao C, Li QM, et al. A new strategy for prenatal diagnosis of homozygous alpha(0)-thalassemia. Ultrasound Obstet Gynecol 2006;28:173–7.
   PubMed Web of Science ®Google Scholar
• Srisupundit K, Piyamongkol W, Tongsong T. Identification of fetuses with hemoglobin Bart's disease using middle cerebral artery peak systolic velocity. Ultrasound Obstet Gynecol 2009;33:694–7.
   PubMed Web of Science ®Google Scholar
• Srisupundit K, Tongprasert F, Luewan S, et al. Splenic circumference at midpregnancy as a predictor of hemoglobin Bart's disease among fetuses at risk. Gynecol Obstet Invest 2011;72:63–7.
   PubMed Web of Science ®Google Scholar
• Tongsong T, Wanapirak C, Sirichotiyakul S. Placental thickness at mid-pregnancy as a predictor of Hb Bart's disease. Prenat Diagn 1999;19:1027–30.
   PubMed Web of Science ®Google Scholar
• Tongsong T, Wanapirak C, Sirichotiyakul S, Chanprapaph P. Sonographic markers of hemoglobin Bart disease at midpregnancy. J Ultrasound Med 2004;23:49–55.
   PubMed Web of Science ®Google Scholar
• Tongsong T, Wanapirak C, Sirichotiyakul S, et al. Middle cerebral artery peak systolic velocity of healthy fetuses in the first half of pregnancy. J Ultrasound Med 2007;26:1013–17.
   PubMed Web of Science ®Google Scholar
• Tongsong T, Tongprasert F, Srisupundit K, Luewan S. High fetal splenic artery peak velocity in fetuses with hemoglobin Bart disease: a preliminary study. J Ultrasound Med 2009;28:13–18.
   PubMed Web of Science ®Google Scholar
• Tongsong T, Piyamongkol W, Tongprasert F, et al. Fetal splenic artery peak velocity (SPA-PSV) at mid-pregnancy as a predictor of Hb Bart's disease. Ultraschall Med 2011;32:S41–5.
   PubMedGoogle Scholar
• Tongprasert F, Wanapirak C, Tongsong T. Maternal serum hCG, PAPP-A and AFP as predictors of hemoglobin Bart disease at mid-pregnancy. Prenat Diagn 2011;31:430–3.
   PubMed Web of Science ®Google Scholar
• Tongprasert F, Wanapirak C, Tongsong T. Maternal serum human chorionic gonadotropin and pregnancy-associated plasma protein-A in pregnancies with fetal homozygous α-thalassemia-1 disease. Prenat Diagn 2012;32:700–2.
   PubMed Web of Science ®Google Scholar
• Tongprasert F, Srisupundit K, Luewan S, Tongsong T. Comparison of maternal serum PlGF and sFlt-1 between pregnancies with and without fetal hemoglobin Bart's disease. Prenat Diagn 2013;33:1272–5.
   PubMed Web of Science ®Google Scholar
• Tongprasert F, Srisupundit K, Luewan S, Tongsong T. Second trimester maternal serum markers and a predictive model for predicting fetal hemoglobin Bart's disease. J Matern Fetal Neonatal Med 2013;26:146–9.
   PubMed Web of Science ®Google Scholar
• Tongprasert F, Srisupundit K, Luewan S, Tongsong T. Second trimester maternal serum alpha-fetoprotein (MSAFP) as predictor of fetal hemoglobin Bart's disease. Prenat Diagn 2014;34:1277–82.
   PubMed Web of Science ®Google Scholar
• Tongprasert F, Srisupundit K, Luewan S, Tongsong T. Second trimester maternal serum inhibin-A in fetal anemia secondary to hemoglobin Bart's disease. J Matern Fetal Neonatal Med 2014;27:1005–9.
   PubMed Web of Science ®Google Scholar
• Chao G, Zheng C, Meng D, et al. Tei index: the earliest detectable cardiac structural and functional abnormality detectable in Hb Bart's foetal edema. Int J Cardiol 2009;134:e150–4.
   PubMed Web of Science ®Google Scholar
• Lam YH, Tang MH, Tse HY. Ductus venosus Doppler study in fetuses with homozygous alpha-thalassemia-1 at 12 to 13 weeks of gestation. Ultrasound Obstet Gynecol 2001;17:30–3.
   PubMed Web of Science ®Google Scholar
• Luewan S, Srisupundit K, Tongprasert F, Tongsong T. Normal reference ranges of inferior vena cava doppler indices from 14 to 40 weeks of gestation. J Clin Ultrasound 2012;40:214–18.
   PubMed Web of Science ®Google Scholar
• Luewan S, Tongprasert F, Srisupundit K, Tongsong T. Fetal myocardial performance (Tei) index in fetal hemoglobin Bart's disease. Ultraschall Med 2013;34:355–8.
   PubMed Web of Science ®Google Scholar
• Luewan S, Tongprasert F, Srisupundit K, et al. Reference ranges of myocardial performance index from 12 to 40 weeks of gestation. Arch Gynecol Obstet 2014;290:859–65.
   PubMed Web of Science ®Google Scholar
• Luewan S, Tongprasert F, Srisupundit K, Tongsong T. Inferior vena cava Doppler indices in fetuses with hemoglobin Bart's hydrops fetalis. Prenat Diagn 2014;34:577–80.
   PubMed Web of Science ®Google Scholar
• Luewan S, Tongprasert F, Srisupundit K, Tongsong T. Fetal cardiac Doppler indices in fetuses with hemoglobin Bart's disease at 12–14 weeks of gestation. Int J Cardiol 2015;184:614–16.
   PubMed Web of Science ®Google Scholar
• Tongsong T, Tongprasert F, Srisupundit K, Luewan S. Venous Doppler studies in low-output and high-output hydrops fetalis. Am J Obstet Gynecol 2010;203:488–6.
   PubMed Web of Science ®Google Scholar
• Tongsong T, Wanapirak C, Piyamongkol W, et al. Fetal ventricular shortening fraction in hydrops fetalis. Obstet Gynecol 2011;117:84–91.
   PubMed Web of Science ®Google Scholar
• Tongprasert F, Srisupundit K, Luewan S, Tongsong T. Comparison of cardiac troponin T and N-terminal pro-B-type natriuretic peptide between fetuses with hemoglobin Bart's disease and nonanemic fetuses. Prenat Diagn 2014;34:864–9.
   PubMed Web of Science ®Google Scholar
• Dwinnell SJ, Coad S, Butler B, et al. In Utero diagnosis and management of a fetus with homozygous alpha-Thalassemia in the second trimester: a case report and literature review. J Pediatr Hematol Oncol 2011;33:e358–60.
   PubMed Web of Science ®Google Scholar
• Ng PC, Fok TF, Lee CH, et al. Is homozygous alpha-thalassaemia a lethal condition in the 1990s? Acta Paediatr 1998;87:1197–9.
   PubMed Web of Science ®Google Scholar
• Thornley I, Lehmann L, Ferguson WS, et al. Homozygous alpha-thalassemia treated with intrauterine transfusions and postnatal hematopoietic stem cell transplantation. Bone Marrow Transplant 2003;32:341–2.
   PubMed Web of Science ®Google Scholar
• Wang C, Ryan G. Transfusion medicine illustrated: intrauterine transfusion for homozygous alpha(0) thalassemia reverses hydrops fetalis. Transfusion 2009;49:1043–4.
   Google Scholar
• Westgren M, Ringden O, Eik-Nes S, et al. Lack of evidence of permanent engraftment after in utero fetal stem cell transplantation in congenital hemoglobinopathies. Transplantation 1996 27;61:1176–9.
   PubMed Web of Science ®Google Scholar
• Yi JS, Moertel CL, Baker KS. Homozygous alpha-thalassemia treated with intrauterine transfusions and unrelated donor hematopoietic cell transplantation. J Pediatr 2009;154:766–8.
   PubMed Web of Science ®Google Scholar
• Sohan K, Billington M, Pamphilon D, et al. Normal growth and development following in utero diagnosis and treatment of homozygous alpha-thalassaemia. BJOG 2002;109:1308–10.
   PubMed Web of Science ®Google Scholar
• Lucke T, Pfister S, Durken M. Neurodevelopmental outcome and haematological course of a long-time survivor with homozygous alpha-thalassaemia: case report and review of the literature. Acta Paediatr 2005;94:1330–3.
   PubMed Web of Science ®Google Scholar
• Chmait RH, Baskin JL, Carson S, et al. Treatment of alpha(0)-thalassemia (–(SEA)/–(SEA)) via serial fetal and post-natal transfusions: Can early fetal intervention improve outcomes?. Hematology 2015;20:217–22.
   PubMed Web of Science ®Google Scholar
• Fung TY, Lau TK, Tam WH, Li CK. In utero exchange transfusion in homozygous alpha-thalassaemia: a case report. Prenat Diagn 1998;18:838–41.
   PubMed Web of Science ®Google Scholar
• Hayward A, Ambruso D, Battaglia F, et al. Microchimerism and tolerance following intrauterine transplantation and transfusion for alpha-thalassemia-1. Fetal Diagn Ther 1998;13:8–14.
   PubMed Web of Science ®Google Scholar
• Chik KW, Shing MM, Li CK, et al. Treatment of hemoglobin Bart's hydrops with bone marrow transplantation. J Pediatr 1998;132:1039–42.
   PubMed Web of Science ®Google Scholar
• Siwawong W, Tongprasert F, Srisupundit K, et al. Fetal cardiac circumference derived by spatiotemporal image correlation as a predictor of fetal hemoglobin Bart disease at midpregnancy. J Ultrasound Med 2013;32:1483–8.
   PubMed Web of Science ®Google Scholar
• Srisupundit K, Piyamongkol W, Tongprasert F, et al. Reference range of fetal splenic circumference from 14 to 40 weeks of gestation. Arch Gynecol Obstet 2011;283:449–53.
   PubMed Web of Science ®Google Scholar
• Singer ST, Styles L, Bojanowski J, et al. Changing outcome of homozygous alpha-thalassemia: cautious optimism. J Pediatr Hematol Oncol 2000;22:539–42.
   PubMed Web of Science ®Google Scholar
• Huang S, Fang J, Chen C, et al. Umbilical cord blood transplantation (UCBT) in thalassemia children. Zhonghua Xue Ye Xue Za Zhi 2001;22:182–5.
   PubMedGoogle Scholar
• Gumuscu B, Thompson EI, Grovas AC, et al. Successful unrelated cord blood transplantation for homozygous α-thalassemia. J Pediatr Hematol Oncol 2013;35:570–2.
   PubMed Web of Science ®Google Scholar